Lazard Asset Management LLC Pfizer Inc Transaction History

Lazard Asset Management LLC

  • $61.8 Billion
  • Q4 2024

A detailed history of Lazard Asset Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 204,200 shares of PFE stock, worth $5.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
204,200
Previous 254,786 19.85%
Holding current value
$5.37 Million
Previous $7.37 Million 26.53%
% of portfolio
0.01%
Previous 0.01%

Shares

47 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$24.8 - $30.19 $1.25 Million - $1.53 Million
-50,586 Reduced 19.85%
204,200 $5.42 Million
Q3 2024

Nov 14, 2024
SELL
$27.7 - $31.39 $390,320 - $442,316
-14,091 Reduced 5.24%
254,786 $7.37 Million
Q2 2024

Aug 14, 2024
SELL
$25.26 - $29.6 $10.8 Million - $12.6 Million
-426,027 Reduced 61.31%
268,877 $7.52 Million
Q1 2024

May 14, 2024
SELL
$25.89 - $29.73 $32.7 Million - $37.6 Million
-1,264,445 Reduced 64.53%
694,904 $19.3 Million
Q4 2023

Feb 14, 2024
SELL
$26.13 - $33.94 $2.62 Million - $3.4 Million
-100,235 Reduced 4.87%
1,959,349 $56.4 Million
Q3 2023

Nov 14, 2023
SELL
$32.09 - $37.51 $5.96 Million - $6.97 Million
-185,703 Reduced 8.27%
2,059,584 $68.3 Million
Q2 2023

Aug 14, 2023
BUY
$36.12 - $41.79 $5.59 Million - $6.47 Million
154,787 Added 7.4%
2,245,287 $82.4 Million
Q1 2023

May 15, 2023
BUY
$39.39 - $51.28 $8.25 Million - $10.7 Million
209,515 Added 11.14%
2,090,500 $85.3 Million
Q4 2022

Feb 14, 2023
BUY
$41.75 - $54.5 $5.11 Million - $6.67 Million
122,416 Added 6.96%
1,880,985 $96.4 Million
Q3 2022

Nov 14, 2022
SELL
$43.76 - $53.42 $6.84 Million - $8.35 Million
-156,287 Reduced 8.16%
1,758,569 $77 Million
Q2 2022

Aug 09, 2022
SELL
$46.53 - $55.17 $7.87 Million - $9.33 Million
-169,091 Reduced 8.11%
1,914,856 $100 Million
Q1 2022

May 13, 2022
BUY
$45.75 - $56.69 $58.4 Million - $72.3 Million
1,275,423 Added 157.75%
2,083,947 $108 Million
Q4 2021

Feb 09, 2022
BUY
$41.32 - $61.25 $104,209 - $154,472
2,522 Added 0.31%
808,524 $47.7 Million
Q3 2021

Nov 15, 2021
SELL
$39.25 - $50.42 $28.1 Million - $36 Million
-714,884 Reduced 47.0%
806,002 $34.7 Million
Q2 2021

Aug 12, 2021
SELL
$35.91 - $40.68 $47.8 Million - $54.2 Million
-1,331,187 Reduced 46.67%
1,520,886 $59.6 Million
Q1 2021

May 14, 2021
SELL
$33.49 - $37.77 $16.3 Million - $18.3 Million
-485,599 Reduced 14.55%
2,852,073 $103 Million
Q4 2020

Feb 11, 2021
SELL
$33.47 - $42.56 $469 Million - $597 Million
-14,016,285 Reduced 80.77%
3,337,672 $123 Million
Q3 2020

Nov 13, 2020
BUY
$31.75 - $37.25 $20.2 Million - $23.6 Million
634,806 Added 3.8%
17,353,957 $637 Million
Q2 2020

Aug 13, 2020
BUY
$30.12 - $36.54 $67.5 Million - $81.8 Million
2,239,574 Added 15.47%
16,719,151 $547 Million
Q1 2020

May 14, 2020
BUY
$27.03 - $38.62 $70.9 Million - $101 Million
2,621,300 Added 22.11%
14,479,577 $473 Million
Q4 2019

Feb 13, 2020
BUY
$32.92 - $37.36 $135 Million - $153 Million
4,098,778 Added 52.82%
11,858,277 $465 Million
Q3 2019

Nov 14, 2019
SELL
$32.49 - $42.13 $52.7 Million - $68.4 Million
-1,623,318 Reduced 17.3%
7,759,499 $279 Million
Q2 2019

Aug 14, 2019
SELL
$36.98 - $41.52 $72.8 Million - $81.8 Million
-1,969,148 Reduced 17.35%
9,382,817 $406 Million
Q1 2019

Aug 28, 2019
SELL
$37.5 - $41.2 $13,312 - $14,626
-355 Reduced -0.0%
11,351,965 $482 Million
Q1 2019

May 13, 2019
SELL
$37.5 - $41.2 $202,275 - $222,232
-5,394 Reduced 0.05%
11,352,320 $482 Million
Q4 2018

Aug 28, 2019
BUY
$38.47 - $43.86 $5.33 Million - $6.08 Million
138,590 Added 1.24%
11,357,714 $496 Million
Q4 2018

Feb 13, 2019
SELL
$38.47 - $43.86 $109 Million - $124 Million
-2,834,172 Reduced 20.17%
11,219,124 $490 Million
Q3 2018

Aug 30, 2019
BUY
$34.47 - $41.81 $6.07 Million - $7.36 Million
176,026 Added 1.27%
14,053,296 $619 Million
Q3 2018

Nov 13, 2018
SELL
$34.47 - $41.81 $26.6 Million - $32.3 Million
-772,396 Reduced 5.27%
13,877,270 $612 Million
Q2 2018

Aug 30, 2019
BUY
$32.98 - $35.16 $6.59 Million - $7.02 Million
199,738 Added 1.38%
14,649,666 $531 Million
Q2 2018

Aug 13, 2018
SELL
$32.98 - $35.16 $135 Million - $144 Million
-4,084,741 Reduced 22.04%
14,449,928 $524 Million
Q1 2018

Aug 28, 2019
BUY
$31.91 - $37.02 $1.61 Million - $1.87 Million
50,528 Added 0.27%
18,534,669 $658 Million
Q1 2018

May 14, 2018
BUY
$31.91 - $37.02 $41.5 Million - $48.2 Million
1,300,940 Added 7.57%
18,484,141 $656 Million
Q4 2017

Aug 28, 2019
BUY
$33.26 - $35.29 $122,563 - $130,043
3,685 Added 0.02%
17,183,201 $622 Million
Q4 2017

Feb 13, 2018
BUY
$33.26 - $35.29 $6.31 Million - $6.7 Million
189,752 Added 1.12%
17,179,516 $622 Million
Q3 2017

Aug 19, 2019
SELL
$31.0 - $34.15 $721,339 - $794,636
-23,269 Reduced 0.14%
16,989,764 $607 Million
Q3 2017

Nov 13, 2017
SELL
$31.0 - $34.15 $4.68 Million - $5.16 Million
-151,110 Reduced 0.88%
17,013,033 $607 Million
Q2 2017

Aug 19, 2019
SELL
N/A
-12,485,730 Reduced 42.11%
17,164,143 $577 Million
Q1 2017

Aug 13, 2019
SELL
N/A
-4,765,664 Reduced 13.85%
29,649,873 $1.01 Billion
Q4 2016

Jul 30, 2019
BUY
N/A
8,084,769 Added 30.7%
34,415,537 $1.12 Billion
Q3 2016

Aug 07, 2019
BUY
N/A
4,084,407 Added 18.36%
26,330,768 $892 Million
Q2 2016

Jul 29, 2019
SELL
N/A
-5,071,308 Reduced 18.56%
22,246,361 $783 Million
Q1 2016

Jul 25, 2019
BUY
N/A
3,915,318 Added 16.73%
27,317,669 $810 Million
Q4 2015

Jul 24, 2019
BUY
N/A
118,936 Added 0.51%
23,402,351 $755 Million
Q3 2015

Jul 15, 2019
BUY
N/A
1,492,955 Added 6.85%
23,283,415 $731 Million
Q2 2015

Jul 08, 2019
BUY
N/A
1,086,072 Added 5.25%
21,790,460 $731 Million
Q4 2014

Aug 29, 2019
BUY
N/A
20,704,388
20,704,388 $645 Million

Others Institutions Holding PFE

# of Institutions
3,354
Shares Held
3.69B
Call Options Held
106M
Put Options Held
123M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email